Unfettered Options Success & More

Huge Options Winners:

We have really been cooking on the options trading front as we cruise back into another earnings season. Both our fresh ideas from yesterday morning’s premarket report, and the longer-term plays that we’ve been tracking have posted premium moves which of course provided us with some elite gain opportunities.

If you’ve been keeping up with our daily reports, you’re already aware that our running targets are the MRNA 08/20 $195-210 Calls and the AN 08/20 $100-105 Calls. Our fresh ideas from yesterday morning were the HAL Weekly $19-20 Calls and the IBM Weekly $140-142 Calls.

We’ve got the daily ranges on those weeklies as well as the new highs posted in our August plays for you right here:

HAL Weekly $19-20 Calls
 .71-1.51 (+113%)
$19.50: .37-1.10 (+197%)
$20: .22-.70 (+218%)

IBM Weekly $140-142 Calls
 .69-1.51 (+119%)
$141: .43-.99 (+130%)
$142: .29-.64 (+121%)

AN 08/20 $100-105 Calls
 3.30-16.10 (+387%)
$105: 2.05-11.90 (+480%)

MRNA 08/20 $195-210 Calls
$195: 23.50-143.95 (+512%)
$200: 18.00-141.80 (+688%)
$210: 13.55-130.35 (+862%)

There’s plenty of runway left in the trading week for these quick-strike plays, and of course a whole month left on the August Calls. We won’t rule out the furtherance of these already impressive uptrends, especially if the markets manage to tack on a second straight day of gains.

Fresh Options Ideas:
JNJ Weekly $167.50-170 Calls
KO Weekly $56.50-57.50 Calls
VZ Weekly $55-57 Calls 

Extended Watchlist:

TOMDF Run Continues

Todos Medical, Ltd. TOMDF

We have been tracking TOMDF since Tuesday morning in the premarket, when we included it in our extended watchlist. At the time, it was trading for as little as .0413 per share, and while it had a solid session that day, the gains hadn’t quite yet cracked the double-bag threshold.

Yesterday, after another really good performance, that mark was attained and then some. TOMDF has gone on to hit a new high of .17 for us, which works out to a big gain of 312%

The company’s rapid (2-10min) COVID-19 point-of-care test has been the primary reason for the stock’s huge moves. We will stay updated on the progress of the company getting the tests put into action, and will be interested to see if more upswings are on the horizon as a result.

Options Recaps

We signaled a range of options in the GILD chain in yesterday morning’s report. with the GILD Weekly $79-81 Calls. Thanks to a pretty good day for the markets, all things considered, we witnessed some very nice moves out of those targets.

Weekly $79-81 Calls
 3.44-8.00 (+133%)
$80: 2.68-7.42 (+177%)
$81: 2.49-6.05 (+143%)

Fresh Ideas:
CRWD Weekly $47.50-50 Calls & 03/27 $52-53.50 Calls

Extended Watchlist:

Blue Horseshoe Stocks: NVAX, NQ & More

Novavax, Inc. NVAX 

NVAX is the latest Ebola-related stock to catch our eye, and while the initial fear that was driving a lot of these plays has calmed as people realize that the virus doesn’t exactly spread like wildfire, there is much being made of efforts to find a working vaccine and NVAX is attempting to answer that call.

The company announced today that it had presented at the 8th Vaccine and ISV Conference in Philadelphia on Sunday on what was called the first Ebola Vaccine Candidate based on the 2014 Guinea strain that caused the current outbreak in West Africa.

The company said it expects to begin Phase I testing by December, so we’re going to add NVAX to our watchlists for the time being. Additionally, the stock is gapping up to the tune of 10% here in the premarket, and the chart appears to have the possibility of a Golden Cross in the making.

NQ Mobile, Inc. NQ

This is a play we’ve tracked continuously since late this spring. After witnessing a nice move back in July from the low $4-range to the mid-$7’s, the stock had been under general consolidation until it found and bounced off of support about 6 weeks ago. It has made a nice steady recovery from that point on, and is gaining more traction this morning as it gaps up in the premarket on the heels of a PR.

The mobile security has just company submitted the necessary back-filings to once again become fully compliant, and no anomalies or adverse findings were uncovered, which adds another dimension to this play.

We also like the space NQ operates in- with mobile devices permeating every aspect of the current culture, the need for mobile security services such as those provided by NQ only stands to grow in the future.

Side Note:
PTIE, DRRX (Two that are gapping down significantly; we will want to watch for an eventual bounce)

Extended Watchlist: